Needham & Company LLC reaffirmed their buy rating on shares of N-able (NYSE:NABL – Free Report) in a research note published on Thursday morning,Benzinga reports. Needham & Company LLC currently has a $8.00 target price on the stock. A number of other equities analysts have also recently issued reports on NABL. Weiss Ratings reaffirmed a […]

Needham & Company LLC reaffirmed their buy rating on shares of Immuneering (NASDAQ:IMRX – Free Report) in a report published on Monday,Benzinga reports. The firm currently has a $11.00 price objective on the stock. Several other equities analysts have also weighed in on the company. Weiss Ratings reissued a “sell (d-)” rating on shares of […]

Needham & Company LLC reiterated their buy rating on shares of Oncology Institute (NASDAQ:TOI – Free Report) in a report released on Monday,Benzinga reports. The brokerage currently has a $5.00 price target on the stock. Separately, Weiss Ratings restated a “sell (d-)” rating on shares of Oncology Institute in a research report on Wednesday, January […]